Myriad Genetics Inc. (MYGN) said that it has entered into a partnership with Gabbi, a telehealth platform specializing in breast cancer risk assessment and specialist care. The companies aim to deliver a comprehensive solution that integrates Gabbi's risk assessment program and access to breast care specialists with Myriad's MyRisk with RiskScore Hereditary Cancer Test. This collaboration seeks to streamline services for individuals seeking advanced breast cancer risk evaluation and specialized care.
Gabbis telehealth solution provides logistics and educational support to assess breast cancer risk. Patients identified as potentially high risk are connected with a Gabbi clinician to be evaluated for the MyRisk Hereditary Cancer Test, ensuring a seamless experience.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.